Epitomee Medical Ltd (EPIT) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.01x

Epitomee Medical Ltd (EPIT) has a Cash Flow Reinvestment Rate of 0.01x as of December 2020, reinvesting ILA179.29K (capex ILA179.29K ) from operating cash flow of ILA27.75 Million. See EPIT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

ILA179.29K

Capex + Investments

Operating Cash Flow

ILA27.75 Million

ILA

Capital Expenditures

ILA179.29K

ILA

Epitomee Medical Ltd Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Epitomee Medical Ltd across 1 annual periods. For the full cash flow conversion analysis, see Epitomee Medical Ltd (EPIT) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Epitomee Medical Ltd (2020–2020)

Year-by-year capital reinvestment analysis for Epitomee Medical Ltd. See EPIT financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2020	2.33x	ILA15.74 Million	ILA6.75 Million	ILA104.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow